61 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
of 5% or more of our Common Shares can requisition a special meeting of shareholders, whereas such right does not exist under the DGCL. We cannot … the results of its annual and special meeting of shareholders held Wednesday, June 28, 2023. A total of 7,482,990 Common Shares (pre 1:9 consolidation
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
On October 3, 2023, the Company mailed proxy circular documents for a special meeting of shareholders to consider a consolidation of the Company’s … , the Company announced the rescheduling of the Meeting to October 27, 2023 (the “Special Meeting”). At the Special Meeting, the Company received shareholder
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:14pm
- Continuous Disclosure Obligations, this report briefly describes the matters voted upon and the outcome of the votes at the Special Meeting
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:13pm
Davidoff
Title:
Chief Executive Officer
EXHIBIT INDEX
99.1
Special Meeting Notice
99.2
Special Meeting Management Information Circular
99.3
Special … OF SPECIAL MEETING OF SHAREHOLDERS
NOTICE IS HEREBY GIVEN that a special meeting (the "Meeting") of the shareholders (the "Shareholders") of XORTX
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
a holder of 5% or more of our Common Shares can requisition a special meeting of shareholders, whereas such right does not exist under the DGCL. We cannot … the results of its annual and special meeting of shareholders held Wednesday, June 28, 2023. A total of 7,482,990 Common Shares (pre 1:9 consolidation
424B3
uokdw8 ewn0
13 Jun 24
Prospectus supplement
4:10pm
424B3
lvz2uo10fgiwf
13 Jun 24
Prospectus supplement
4:09pm
424B3
2ltcnv wcrqhj
13 Jun 24
Prospectus supplement
4:08pm
424B5
qlj4 v7vzgxlkb
29 Nov 23
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.2
w9j3k48 0j4
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
6-K
EX-99.1
24d rz7uhgzs
13 Nov 23
Current report (foreign)
7:00am
6-K
EX-99.1
wmafk91weq m0
8 Nov 23
XORTX Announces Share Consolidation
5:00pm
6-K
EX-99.1
xo7gcj01z9pwl
27 Oct 23
XORTX Announces Results of Special Meeting of Shareholders
6:05pm
6-K
EX-99.1
n9lt79e 8u
27 Oct 23
Current report (foreign)
6:04pm
6-K
EX-99.1
yv6at0asyeyrr0
25 Oct 23
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
5:00pm
6-K
EX-99.1
bpgzqtv2
25 Oct 23
XORTX Announces Rescheduling of Special Meeting of Shareholders
7:00am
6-K
EX-99.1
2hl4zj
12 Oct 23
XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
7:41am
6-K
EX-99.1
gd37 1czxm
4 Oct 23
XORTX Calls Special Meeting of Shareholders
1:11pm